432 related articles for article (PubMed ID: 14567189)
21. Phospholipid metabolites, prognosis and proliferation in human breast carcinoma.
Smith TA; Bush C; Jameson C; Titley JC; Leach MO; Wilman DE; McCready VR
NMR Biomed; 1993; 6(5):318-23. PubMed ID: 8268064
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity.
Fallbrook A; Turenne SD; Mamalias N; Kish SJ; Ross BM
Brain Res; 1999 Jul; 834(1-2):207-10. PubMed ID: 10407117
[TBL] [Abstract][Full Text] [Related]
23. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
[TBL] [Abstract][Full Text] [Related]
24. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
25. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate.
Smith TA; Eccles S; Ormerod MG; Tombs AJ; Titley JC; Leach MO
Br J Cancer; 1991 Nov; 64(5):821-6. PubMed ID: 1931601
[TBL] [Abstract][Full Text] [Related]
26. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
[TBL] [Abstract][Full Text] [Related]
27. Identification of components of phospholipids metabolism in automated phosphate ester chromatography.
Geiger PJ; Roberts CM
Biochem Biophys Res Commun; 1979 May; 88(2):508-14. PubMed ID: 465052
[No Abstract] [Full Text] [Related]
28. Ilexgenin A induces B16-F10 melanoma cell G1/S arrest in vitro and reduces tumor growth in vivo.
Yang H; Liu C; Zhang YQ; Ge LT; Chen J; Jia XQ; Gu RX; Sun Y; Sun WD
Int Immunopharmacol; 2015 Feb; 24(2):423-431. PubMed ID: 25596038
[TBL] [Abstract][Full Text] [Related]
29. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
Hill RP; Stanley JA
Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
[TBL] [Abstract][Full Text] [Related]
30. Methionine-dependence phenotype of tumors: metabolite profiling in a melanoma model using L-[methyl-13C]methionine and high-resolution magic angle spinning 1H-13C nuclear magnetic resonance spectroscopy.
Morvan D; Demidem A; Guenin S; Madelmont JC
Magn Reson Med; 2006 May; 55(5):984-96. PubMed ID: 16598721
[TBL] [Abstract][Full Text] [Related]
31. Phospholipid synthesis in the lymphomatous mouse liver studied by 31P nuclear magnetic resonance spectroscopy in vitro and by administration of 14C-radiolabelled compounds in vivo.
Dixon RM; Tian M
Biochim Biophys Acta; 1993 Apr; 1181(2):111-21. PubMed ID: 8481399
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumour activity of a new series of nitrosoureido sugars.
Monneret C; Rissé S; Ardouin P; Gouyette A
Eur J Med Chem; 2000 Jan; 35(1):137-46. PubMed ID: 10733610
[TBL] [Abstract][Full Text] [Related]
33. Effect of radiotherapy and chemotherapy on composition of tumor membrane phospholipids.
Street JC; Koutcher JA
Lipids; 1997 Jan; 32(1):45-9. PubMed ID: 9075192
[TBL] [Abstract][Full Text] [Related]
34. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma].
Zhang H; Feng Z; Zhang G
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):416-8. PubMed ID: 11776614
[TBL] [Abstract][Full Text] [Related]
35. Metabolomic profiling with NMR discriminates between biphosphonate and doxorubicin effects on B16 melanoma cells.
Triba MN; Starzec A; Bouchemal N; Guenin E; Perret GY; Le Moyec L
NMR Biomed; 2010 Nov; 23(9):1009-16. PubMed ID: 20963798
[TBL] [Abstract][Full Text] [Related]
36. In vivo and ex vivo study of metabolic and cellular effects of 5-fluorouracil chemotherapy in a mouse mammary carcinoma.
Street JC; Alfieri AA; Traganos F; Koutcher JA
Magn Reson Imaging; 1997; 15(5):587-96. PubMed ID: 9254003
[TBL] [Abstract][Full Text] [Related]
37. The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells.
Haase R; Wieder T; Geilen CC; Reutter W
FEBS Lett; 1991 Aug; 288(1-2):129-32. PubMed ID: 1879545
[TBL] [Abstract][Full Text] [Related]
38. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Atassi G; Dumont P; Gosse C; Fournier JP; Gouyette A; Roger P
Cancer Chemother Pharmacol; 1989; 25(3):205-9. PubMed ID: 2598412
[TBL] [Abstract][Full Text] [Related]
40. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Stephens TC; Peacock JH
Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
